Literature DB >> 20593492

Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces.

Joanna L James1, Guy S Whitley, Judith E Cartwright.   

Abstract

The success of pregnancy is a result of countless ongoing interactions between the placenta and the maternal immune and cardiovascular systems. Pre-eclampsia is a serious pregnancy complication that arises from multiple potential aberrations in these systems. The pathophysiology of pre-eclampsia is established in the first trimester of pregnancy, when a range of deficiencies in placentation affect the key process of spiral artery remodelling. As pregnancy progresses to the third trimester, inadequate spiral artery remodelling along with multiple haemodynamic, placental and maternal factors converge to activate the maternal immune and cardiovascular systems, events which may in part result from increased shedding of placental debris. As we understand more about the pathophysiology of pre-eclampsia, it is becoming clear that the development of early- and late-onset pre-eclampsia, as well as intrauterine growth restriction (IUGR), does not necessarily arise from the same underlying pathology.

Entities:  

Mesh:

Year:  2010        PMID: 20593492     DOI: 10.1002/path.2719

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  49 in total

1.  Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thickness.

Authors:  A Sood; S Salih; D Roh; L Lacharme-Lora; M Parry; B Hardiman; R Keehan; R Grummer; E Winterhager; P J Gokhale; P W Andrews; C Abbott; K Forbes; M Westwood; J D Aplin; E Ingham; I Papageorgiou; M Berry; J Liu; A D Dick; R J Garland; N Williams; R Singh; A K Simon; M Lewis; J Ham; L Roger; D M Baird; L A Crompton; M A Caldwell; H Swalwell; M Birch-Machin; G Lopez-Castejon; A Randall; H Lin; M-S Suleiman; W H Evans; R Newson; C P Case
Journal:  Nat Nanotechnol       Date:  2011-11-06       Impact factor: 39.213

2.  Acute neurological issues in pregnancy and the peripartum.

Authors:  Catherine M Hosley; Louise D McCullough
Journal:  Neurohospitalist       Date:  2011-04

3.  Oocyte donation: a risk factor for pregnancy-induced hypertension: a meta-analysis and case series.

Authors:  Ulrich Pecks; Nicolai Maass; Joseph Neulen
Journal:  Dtsch Arztebl Int       Date:  2011-01-21       Impact factor: 5.594

4.  Association of Placental Jets and Mega-Jets With Reduced Villous Density.

Authors:  Rojan Saghian; Joanna L James; Merryn H Tawhai; Sally L Collins; Alys R Clark
Journal:  J Biomech Eng       Date:  2017-05-01       Impact factor: 2.097

5.  Midgestation maternal serum 25-hydroxyvitamin D level and soluble fms-like tyrosine kinase 1/placental growth factor ratio as predictors of severe preeclampsia.

Authors:  Padmashree Chaudhury Woodham; Julia E Brittain; Arthur M Baker; D Leann Long; Sina Haeri; Carlos A Camargo; Kim A Boggess; Alison M Stuebe
Journal:  Hypertension       Date:  2011-10-10       Impact factor: 10.190

6.  Polymorphisms in Inflammatory Mediator Genes and Risk of Preeclampsia in Taiyuan, China.

Authors:  Weiwei Wu; Hailan Yang; Yongliang Feng; Ping Zhang; Shuzhen Li; Xin Wang; Tingting Peng; Fang Wang; Bingjie Xie; Pengge Guo; Mei Li; Ying Wang; Nan Zhao; Suping Wang; Yawei Zhang
Journal:  Reprod Sci       Date:  2016-08-04       Impact factor: 3.060

7.  Polymorphisms in complement genes and risk of preeclampsia in Taiyuan, China.

Authors:  Weiwei Wu; Hailan Yang; Yongliang Feng; Ping Zhang; Shuzhen Li; Xin Wang; Tingting Peng; Fang Wang; Bingjie Xie; Pengge Guo; Mei Li; Ying Wang; Nan Zhao; Dennis Wang; Suping Wang; Yawei Zhang
Journal:  Inflamm Res       Date:  2016-07-12       Impact factor: 4.575

8.  Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

Authors:  H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

Review 9.  Drug treatment of hypertension in pregnancy.

Authors:  Catherine M Brown; Vesna D Garovic
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

10.  Antibodies anti-CagA cross-react with trophoblast cells: a risk factor for pre-eclampsia?

Authors:  Francesco Franceschi; Nicoletta Di Simone; Silvia D'Ippolito; Roberta Castellani; Fiorella Di Nicuolo; Giovanni Gasbarrini; Yoshio Yamaoka; Tullia Todros; Giovanni Scambia; Antonio Gasbarrini
Journal:  Helicobacter       Date:  2012-06-29       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.